Related references
Note: Only part of the references are listed.Red blood cells treated with the amustaline (S-303) pathogen reduction system: a transfusion study in cardiac surgery
Veronika Brixner et al.
TRANSFUSION (2018)
Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion-associated graft-versus-host disease
Grace Castro et al.
TRANSFUSION (2018)
Hemovigilance monitoring of platelet septic reactions with effective bacterial protection systems
Richard J. Benjamin et al.
TRANSFUSION (2017)
Red blood cell concentrates treated with the amustaline (S-303) pathogen reduction system and stored for 35 days retain post-transfusion viability: results of a two-centre study
J. A. Cancelas et al.
VOX SANGUINIS (2017)
Prevention of transfusion-associated graft-versus-host disease with pathogen-reduced platelets with amotosalen and ultraviolet A light: a review
J. Cid
VOX SANGUINIS (2017)
Benefit of STR-based chimerism analysis to identify TA-GVHD as a cause of death: Utility of various biological specimens
Anupuma Raina et al.
MEDICINE SCIENCE AND THE LAW (2016)
Survey of Irradiation Practice for the Prevention of Transfusion-Associated Graft-versus-Host Disease
Aaron E. Pritchard et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2016)
Hemovigilance survey of pathogen-reduced blood components in the Warsaw Region in the 2009 to 2013 period
Magdalena Letowska et al.
TRANSFUSION (2016)
A systematic review of transfusion-associated graft-versus-host disease
Ilana Kopolovic et al.
BLOOD (2015)
Cost implications of implementation of pathogen-inactivated platelets
Jeffrey McCullough et al.
TRANSFUSION (2015)
A prospective, active haemovigilance study with combined cohort analysis of 19 175 transfusions of platelet components prepared with amotosalen-UVA photochemical treatment
F. Knutson et al.
VOX SANGUINIS (2015)
Pathogen reduction by ultraviolet C light effectively inactivates human white blood cells in platelet products
Petra Pohler et al.
TRANSFUSION (2015)
The effect of timing of gamma-irradiation on hemolysis and potassium release in leukoreduced red cell concentrates stored in SAGM
K. Serrano et al.
VOX SANGUINIS (2014)
Transfusion-associated graft-versus-host disease in a liver transplant recipient: an unusual presentation and review of the literature
Kerry L. O'Brien et al.
TRANSFUSION (2013)
Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease?
Loren D. Fast et al.
TRANSFUSION (2013)
Analysis of 66 patients definitive with transfusion-associated graft-versus-host disease and the effect of universal irradiation of blood
S. Uchida et al.
TRANSFUSION MEDICINE (2013)
Transfusion-Associated Microchimerism: The Hybrid Within
Evan M. Bloch et al.
TRANSFUSION MEDICINE REVIEWS (2013)
Developments in the prevention of transfusion-associated graft-versus-host disease
Loren D. Fast
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force
Jennie Treleaven et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Mouse models of graft-versus-host disease: advances and limitations
Mark A. Schroeder et al.
DISEASE MODELS & MECHANISMS (2011)
Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation
Loren D. Fast et al.
TRANSFUSION (2011)
Cesium cessation? An advantage of pathogen reduction treatments
Paul D. Mintz
TRANSFUSION (2011)
How do we prevent transfusion-associated graft-versus-host disease in children?
Karen E. King et al.
TRANSFUSION (2011)
Stored red blood cell viability is maintained after treatment with a second-generation S-303 pathogen inactivation process
Jose A. Cancelas et al.
TRANSFUSION (2011)
Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood System™
Johannes Irsch et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2011)
Treatment of whole blood (WB) and red blood cells (RBC) with S-303 inactivates pathogens and retains in vitro quality of stored RBC
N. A. Mufti et al.
BIOLOGICALS (2010)
Transfusion-associated graft-versus-host disease presenting as severe high-volume diarrhoea in a patient with Goodpasture's syndrome
Karin Amrein et al.
INTENSIVE CARE MEDICINE (2010)
Nonlethal, attenuated, transfusion-associated graft-versus-host disease in an immunocompromised child: case report and review of the literature
Joao F. Neves et al.
TRANSFUSION (2010)
Irradiation eradication and pathogen reduction. Ceasing cesium irradiation of blood products
P. D. Mintz et al.
BONE MARROW TRANSPLANTATION (2009)
Transfusion-Associated Graft-Versus-Host Disease
Heiko Ruehl et al.
TRANSFUSION MEDICINE REVIEWS (2009)
Transfusion-associated graft-versus-host disease
D. M. Dwyre et al.
VOX SANGUINIS (2008)
The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease
Lorna M. Williamson et al.
TRANSFUSION (2007)
Transfusion-associated graft-versus-host disease in immunocompetent patients: case series and review of the literature
Kemal Agbaht et al.
TRANSFUSION (2007)
Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells
D Triulzi et al.
TRANSFUSION (2006)
Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients
RJ Benjamin et al.
TRANSFUSION (2005)
Comparison of X-ray vs. gamma irradiation of CPDA-1 red cells
K Janatpour et al.
VOX SANGUINIS (2005)
Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment
L Lin et al.
TRANSFUSION (2005)
Minors come of age: Minor histocompatibility antigens and graft-versus-host disease
NJ Chao
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria
L Lin et al.
TRANSFUSION (2004)
Transfusion-associated GVHD: 10 years' experience at the American university of Beirut - Medical center
E Aoun et al.
TRANSFUSION (2003)
Nonlethal transfusion associated graft-versus-host disease in a severe combined immunodefficient patient
A van Royen-Kerkhof et al.
BONE MARROW TRANSPLANTATION (2003)
Transfusion-associated graft-versus-host disease
ML Schroeder
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Guidelines for irradiation of blood and blood components to prevent post-transfusion graft-vs.-host disease in Japan
T Asai et al.
TRANSFUSION MEDICINE (2000)
Irreversible loss of donor blood leucocyte activation may explain a paucity of transfusion-associated graft-versus-host disease from stored blood
H Chang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Assessment of donor T-cell function in cellular blood components by the CD69 induction assay:: effects of storage, γ radiation, and photochemical treatment
E Fiebig et al.
TRANSFUSION (2000)
Irradiation of platelet components: inhibition of lymphocyte proliferation assessed by limiting-dilution analysis
NLC Luban et al.
TRANSFUSION (2000)
Share Paper
